What Is Intelligent Bio Solutions Inc. (INBS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Intelligent Bio Solutions Inc.. Trading at $2.30 against an estimated intrinsic value of $4.34, 10 of 11 active models flag meaningful upside of +88.5% on average. The most optimistic model, FTNN, places fair value at $6.06 (+163.3%), while Bayesian DCF — the most conservative — estimates $1.92 (-16.4%). This +179.7% gap reflects genuine analytical uncertainty about Intelligent Bio Solutions Inc.'s intrinsic worth.
What Do the Models Say About INBS?
11 of 13 models are currently active for INBS. Of these, 10 models suggest upside while 1 model suggests overvaluation. The Bayesian DCF estimates INBS's intrinsic value at $1.92, implying -16.4% downside from the current price. See which stocks rank higher →
How Does INBS Rank in Surgical & Medical Instruments & Apparatus?
Among 111 Surgical & Medical Instruments & Apparatus stocks, INBS ranks #80 by Quality of Company score. CirclFi's QOC score of 5.4/10 evaluates 32 fundamental signals. A score of 5.4 reflects mixed fundamentals.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
Intelligent Bio Solutions Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is INBS a Value Trap?
CirclFi's Value Trap algorithm assigns INBS a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Intelligent Bio Solutions Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Intelligent Bio Solutions Inc. scores 5.4 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +179.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every INBS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across INBS's 11 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad